Dr. Clay Cauthen, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $76,355 | 29 | 64.3% |
| Travel and Lodging | $20,077 | 40 | 16.9% |
| Food and Beverage | $7,162 | 184 | 6.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $5,700 | 8 | 4.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,998 | 3 | 4.2% |
| Consulting Fee | $4,463 | 4 | 3.8% |
| Education | $7.12 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $90,490 | 131 | $0 (2024) |
| Abbott Laboratories | $20,848 | 53 | $0 (2022) |
| PFIZER INC. | $5,161 | 6 | $0 (2021) |
| Medtronic Vascular, Inc. | $427.47 | 6 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $335.40 | 23 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $256.74 | 23 | $0 (2019) |
| HeartFlow, Inc. | $249.34 | 2 | $0 (2019) |
| ABIOMED | $246.29 | 4 | $0 (2021) |
| Intuitive Surgical, Inc. | $186.61 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $178.58 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31.11 | 1 | Novartis Pharmaceuticals Corporation ($31.11) |
| 2022 | $205.56 | 2 | Abbott Laboratories ($205.56) |
| 2021 | $8,371 | 10 | Abbott Laboratories ($5,700) |
| 2020 | $12,065 | 23 | Abbott Laboratories ($9,286) |
| 2019 | $25,809 | 74 | Novartis Pharmaceuticals Corporation ($19,901) |
| 2018 | $45,088 | 76 | Novartis Pharmaceuticals Corporation ($44,226) |
| 2017 | $27,191 | 84 | Novartis Pharmaceuticals Corporation ($26,333) |
All Payment Transactions
270 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $31.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2022 | Abbott Laboratories | TENDRIL (Device) | Food and Beverage | In-kind items and services | $105.56 | General |
| Category: Cardiac Rhythm Management | ||||||
| 03/14/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Heart Failure | ||||||
| 09/22/2021 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $145.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/13/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,375.00 | General |
| Category: Heart Failure | ||||||
| 05/13/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $475.00 | General |
| Category: Heart Failure | ||||||
| 05/13/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $475.00 | General |
| Category: Heart Failure | ||||||
| 05/13/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $237.50 | General |
| Category: Heart Failure | ||||||
| 05/13/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $237.50 | General |
| Category: Heart Failure | ||||||
| 05/13/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $237.50 | General |
| Category: Heart Failure | ||||||
| 05/03/2021 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,525.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/04/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $950.00 | General |
| Category: Heart Failure | ||||||
| 03/04/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $712.50 | General |
| Category: Heart Failure | ||||||
| 12/10/2020 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,525.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2020 | PFIZER INC. | VYNDAQEL (Drug) | Education | In-kind items and services | $3.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2020 | PFIZER INC. | VYNDAQEL (Drug) | Education | In-kind items and services | $3.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2020 | Boston Scientific Corporation | GENERAL - THERAPIES (Device) | Food and Beverage | In-kind items and services | $122.05 | General |
| Category: THERAPIES | ||||||
| 10/21/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/19/2020 | Abbott Laboratories | HeartMate (Device) | Consulting Fee | Cash or cash equivalent | $1,785.00 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/19/2020 | Abbott Laboratories | HeartMate (Device) | Consulting Fee | Cash or cash equivalent | $714.00 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/19/2020 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $129.18 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/19/2020 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $111.03 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/18/2020 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/13/2020 | Abbott Laboratories | HeartMate (Device) | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $2,856.00 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/13/2020 | Abbott Laboratories | HeartMate (Device) | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $1,606.50 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 325 | 750 | $242,897 | $61,078 |
| 2022 | 12 | 316 | 675 | $203,715 | $50,596 |
| 2021 | 11 | 418 | 711 | $222,866 | $58,518 |
| 2020 | 12 | 461 | 970 | $291,257 | $73,447 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 110 | $74,030 | $17,727 | 23.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 48 | 139 | $44,063 | $12,297 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 71 | 158 | $37,604 | $10,388 | 27.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 75 | $16,575 | $4,328 | 26.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 53 | 76 | $17,136 | $3,859 | 22.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 27 | $16,632 | $3,628 | 21.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 21 | 34 | $11,458 | $3,563 | 31.1% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $12,661 | $2,769 | 21.9% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 12 | 78 | $10,998 | $2,119 | 19.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 19 | 30 | $1,140 | $270.88 | 23.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Facility | 2023 | 12 | 12 | $600.00 | $130.90 | 21.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 24 | 88 | $59,224 | $14,919 | 25.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 113 | $35,821 | $8,850 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 71 | 137 | $32,606 | $8,609 | 26.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 29 | $17,864 | $4,298 | 24.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 61 | $13,481 | $3,386 | 25.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 49 | 60 | $13,568 | $3,241 | 23.9% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 16 | 93 | $13,113 | $2,881 | 22.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 18 | 25 | $8,425 | $2,279 | 27.0% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 12 | 12 | $4,776 | $1,077 | 22.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 11 | 11 | $2,717 | $575.76 | 21.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Facility | 2022 | 30 | 31 | $1,550 | $337.13 | 21.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 11 | 15 | $570.00 | $142.81 | 25.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 24 | 82 | $55,186 | $14,134 | 25.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 76 | 159 | $37,842 | $11,226 | 29.7% |
About Dr. Clay Cauthen, MD
Dr. Clay Cauthen, MD is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730396862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clay Cauthen, MD has received a total of $118,761 in payments from pharmaceutical and medical device companies, with $31.11 received in 2024. These payments were reported across 270 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($76,355).
As a Medicare-enrolled provider, Cauthen has provided services to 1,520 Medicare beneficiaries, totaling 3,106 services with total Medicare billing of $243,639. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Location Austin, TX
- Active Since 05/17/2007
- Last Updated 05/14/2025
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1730396862
Products in Payments
- ENTRESTO (Drug) $90,459
- CardioMEMS HF System (Device) $8,353
- HeartMate (Device) $7,591
- VYNDAQEL (Drug) $5,148
- Ensite Cardiac Mapping System (Device) $1,521
- HeartMate 3 Left Ventricular Dev (Device) $1,451
- Cardiovascular- Research only (Device) $1,163
- Circulatory Support (Device) $542.19
- HeartWare HVAD (Device) $383.58
- LifeVest (Device) $335.40
- Impella (Device) $246.29
- Da Vinci Surgical System (Device) $186.61
- FARXIGA (Drug) $124.95
- GENERAL - THERAPIES (Device) $122.05
- OPSUMIT (Drug) $117.08
- OPSUMIT MACITENTAN (Drug) $105.97
- TENDRIL (Device) $105.56
- CARDIOMEMS (Device) $100.00
- Corlanor (Drug) $63.83
- BRILINTA (Drug) $56.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Advanced Heart Failure and Transplant Cardiology Doctors in Austin
Dr. Kunjan Bhatt, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $332,465
Dr. Raymond Bietry, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $19,242
Andrew Cheng, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $4,714